Evidence map›Paper›PMID 36450851›Full record

ArticleNature biotechnology2023

Author Correction: m

Lulu Hu, Shun Liu, Yong Peng, Ruiqi Ge, Rui Su, Chamara Senevirathne, Bryan T Harada, Qing Dai, Jiangbo Wei, Lisheng Zhang and 8 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

  • Erratum for
    m2022
5 · Who and what money

Authors and funding

18 authors.

Lulu Hu *Department of Chemistry, The University of Chicago, Chicago, IL, USA. luluhu@fudan.edu.cn.ORCID http://orcid.org/0000-0001-7246-1736
Shun Liu *Department of Chemistry, The University of Chicago, Chicago, IL, USA.
Yong Peng *Department of Chemistry, The University of Chicago, Chicago, IL, USA.
Ruiqi Ge *Department of Chemistry, The University of Chicago, Chicago, IL, USA.
Rui Su *Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, USA.ORCID http://orcid.org/0000-0002-4807-6229
Chamara SenevirathneChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Bryan T HaradaDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-9683-782X
Qing DaiDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-8578-1568
Jiangbo WeiDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-2691-6490
Lisheng ZhangDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.
Ziyang HaoDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.
Liangzhi LuoDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.
Huanyu WangDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.
Yuru WangDepartment of Chemistry, The University of Chicago, Chicago, IL, USA.
Minkui LuoChemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0001-7409-7034
Mengjie ChenSection of Genetic Medicine, Department of Medicine, The University of Chicago, Chicago, IL, USA. mengjiechen@uchicago.edu.ORCID http://orcid.org/0000-0003-1579-087X
Jianjun ChenDepartment of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA, USA. jianchen@coh.org.ORCID http://orcid.org/0000-0003-3749-2902
Chuan HeDepartment of Chemistry, The University of Chicago, Chicago, IL, USA. chuanhe@uchicago.edu.ORCID http://orcid.org/0000-0003-4319-7424

Funding

Transcriptome-wide base-resolution sequencing of pseudouridine in human normal and AD brain tissues-CEGS Admin supplement 2020-2021RM1HG008935 · NHGRI · UNIVERSITY OF CHICAGO · PI HE, CHUAN · 2016 to 2025
$24.4M
New directions in single cell genomics method developmentR01GM126553 · NIGMS · UNIVERSITY OF CHICAGO · PI Mengjie Chen · 2017 to 2026
$2.9M
The role and mechanism of METTL3/METTL14-mediated RNA modification in the pathogenesis and drug-resistance of AMLR01CA236399 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI CHEN, JIANJUN · 2019 to 2023
$2.3M
Targeting TET1 signaling to treat acute myeloid leukemiaR01CA211614 · NCI · UNIVERSITY OF CINCINNATI · PI CHEN, JIANJUN · 2017 to 2021
$2.3M
The function and underlying mechanism of TET1 in myelodysplastic syndromesR01DK124116 · NIDDK · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI CHEN, JIANJUN · 2020 to 2023
$2.2M
The role and mechanism of FTO in leukemogenesis and drug responseR01CA214965 · NCI · UNIVERSITY OF CINCINNATI · PI CHEN, JIANJUN · 2017 to 2021
$2.1M
The role of mRNA methylation in the progression of endometrial cancerF32CA221007 · NCI · UNIVERSITY OF CHICAGO · PI HARADA, BRYAN TSUTOMU · 2017 to 2019
$179k
NCI NIH HHS F32 CA221007NCI NIH HHS R01 CA211614NCI NIH HHS R01 CA214965NCI NIH HHS R01 CA236399NHGRI NIH HHS RM1 HG008935NIDDK NIH HHS R01 DK124116NIGMS NIH HHS R01 GM126553
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36450851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.